✦ LIBER ✦

Gefitinib (ZD1839, Iressa®) in non-small-cell lung cancer: a review of clinical trials from a daily practice perspective

✍ Scribed by Fabrice Barlési; Cécile Tchouhadjian; Christophe Doddoli; Patrick Villani; Laurent Greillier; Jean-Pierre Kleisbauer; Pascal Thomas; Philippe Astoul

Book ID: 111194183
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 98 KB
Volume: 19
Category: Article
ISSN: 0767-3981
DOI: 10.1111/j.1472-8206.2005.00323.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New perspectives in the management of no

New perspectives in the management of non-small cell lung cancer (NSCLC): Gefitinib (Iressa, ZD 1839)

✍ C. Manegold 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 280 KB

O-113 Clinical evaluation of gefitinib (

O-113 Clinical evaluation of gefitinib (Iressa, ZD1839) in combination with rofecoxib in cisplatin pre-treated relapsed non-small cell lung cancer

✍ O'Byrne, K.J.; Clarke, L.; Dunlop, D.; Ranson, Malcolm; Danson, S.; Botwood, N. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 182 KB

P-624 A pilot trial of gefitinib (‘Iress

P-624 A pilot trial of gefitinib (‘Iressa’, ZD1839) in combination with docetaxel in patients with advanced or metastatic non-small-cell lung cancer: safety results

✍ Manegold, C.; Gatzemeier, U.; Buchhoiz, E.; Smith, R.; Averbuch, S.; Fandi, A. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 192 KB

P-587 Experience from a large multi-cent

P-587 Experience from a large multi-centre expanded access programme (EAP) with gefitinib (‘Iressa’, ZD1839) as monotherapy in advanced non-small cell lung cancer (NSCLC)

✍ van Puijenbroek, R.; Bosquée, L.; Tits, G.; Germonpre, P.; Strobbe, E.; Vansteen 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 294 KB

Dramatic effect of ZD1839 (‘Iressa’) in

Dramatic effect of ZD1839 (‘Iressa’) in a patient with advanced non-small-cell lung cancer and poor performance status

✍ Fujiwara, Keiichi; Kiura, Katsuyuki; Ueoka, Hiroshi; Tabata, Masahiro; Hamasaki, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Evaluation of safety and efficacy of gef

Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme

✍ Xin-Lin Mu; Long-Yun Li; Xiao-Tong Zhang; Shu-Lan Wang; Meng-Zhao Wang 📂 Article 📅 2004 🏛 BioMed Central 🌐 English ⚖ 293 KB